Atomwise

About Atomwise

Atomwise applies machine learning to small-molecule drug discovery. Its platform searches enormous libraries of chemical compounds to predict which ones might bind to a disease target, narrowing the field before lab work begins. Pharma and biotech partners use it to find starting points for hard targets and to cut the cost of early screening. The company describes its work as exploring chemical space for new molecules, with an emphasis on biological relevance and speed. Atomwise is a paid service, selling research partnerships to organizations that run drug discovery programs.